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Life after Pediatric Critical Illness: Risk Factors for Reduced
Health-related Quality of Life and Functional Decline
Survivors of a critical illness are at risk to develop physical,
cognitive, and psychological impairments that can persist for
months to years after they leave the hospital. Health-related
quality of life (HRQL) and functional abilities are important
measures of outcomes after a critical illness, as they reﬂect not only
the effects of the critical illness, its treatment, and comorbid
illness but also physical disability, cognitive impairment, and
psychological disorders (depression, anxiety, and post-traumatic
stress disorder) after a critical illness in adults (1). A review of HRQL
in 557 adult survivors of acute respiratory distress syndrome found a
substantially lower HRQL in both physical and mental components
compared with age- and sex-matched healthy populations, which
was associated with functional disability (2). The preponderance of
evidence regarding long-term outcomes after a critical illness comes
from adult ICU populations, and less is known about long-term
outcomes for children after a critical illness. Children admitted to a
pediatric ICU (PICU) have increased vulnerability to develop new or
worsening long-term morbidities, including a reduced quality of life
and new functional disability. For example, studies of children who
had been admitted to a PICU found that they had a reduced HRQL
(3) and a high rate of functional disability (up to 82%) after they
were discharged from the hospital (4). These ﬁndings suggest that,
like adult populations, many PICU survivors develop physical,
cognitive, and psychological impairments that are associated with
reduced HRQL and functional disability.
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Although the data regarding HRQL and functional outcomes
after a pediatric critical illness have increased in the past 10 years, there
are few data regarding risk factors associated with a reduced HRQL
or functional decline after pediatric respiratory failure. It is important to
understand the risk factors for post-ICU morbidities in pediatric
populations in order to understand the full effects of critical illness in
children and to identify potential interventions to prevent or improve
outcomes. In a study presented in this issue of the Journal, Watson and
colleagues (pp. 900–909) evaluated risk factors for a post-PICU
decline in functioning and reduced HRQL in children with respiratory
failure (5). Children 2 weeks to 17 years of age who were enrolled in
the RESTORE (Randomized Evaluation of Sedation Titration for
Respiratory Failure) trial were included in the study. Age-appropriate,
validated measures of HRQL and functional abilities were assessed at
6 months after PICU discharge via medical record reviews of
baseline functioning and parental interviews, and postdischarge
functional status and HRQL were assessed by telephone interviews.
The parents/guardians of 960 patients were interviewed, and 91%
of these patients were discharged home and 6% were discharged
to a rehabilitation or assisted-living facility (5).
Post-PICU morbidity was common in pediatric patients with
acute respiratory failure. The prevalence of functional decline was
20%, and 19% of the patients had a reduced quality of life. Among
patients with normal baseline functioning, 49% had functional
decline and 19% had reduced HRQL. Risk factors included
sociodemographic factors, preexisting health status, and factors
associated with the critical illness factors that occurred during the
child’s hospital course (see Table 1 for a summary) (5). The
authors found that the magnitude of the new morbidities was
similar to that observed in severe underlying diseases such as
cancer (5). Similar to ﬁndings in adults (6), the trajectories of
outcomes were variable and included a continued decline over
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Table 1. Multivariable Risk Factors for Functional Impairment and Reduced Health-related Quality of Life

Outcomes

Sociodemographic
Factors

Preexisting
Health Factors

Hospital
Course Factors

Decline in functioning

NA

Baseline impaired function
Prematurity
Cancer

Etiology of respiratory failure
Duration of mechanical ventilation
Clonidine

Impaired growth and development*

NA

Receipt of methadone
Inadequate pain management

NA

Health-related
quality of life

Older age
Non-white or Hispanic

Cancer

Inadequate sedation management

Definition of abbreviation: NA = not applicable.
*Independent risk factors.

time, improvement over time, no change over time, and
decline and then improvement. The etiology of the risk factors
is likely multifactorial. Importantly, comorbid disease and impaired
baseline function increased the risk of poor outcomes (5).
Support for the ﬁndings of Watson and colleagues comes from
a multicenter study that found that in patients with a trauma or
oncologic or neurologic diagnosis, unscheduled admission to the
PCIU, mechanical ventilation, renal replacement therapy,
cardiopulmonary resuscitation, and extracorporeal membrane
oxidation were risk factors for a new functional disability (7). A
retrospective study found that PICU patients with multiple organ
dysfunction on Day 1 of the study had worse functional disability
than children who did not have multiple organ dysfunction (8).
Although they were not assessed in the study by Watson and
colleagues (5), similar risk factors for cognitive impairments have
been identiﬁed after a pediatric critical illness, including younger
age, lower socioeconomic status, mechanical ventilation, high
oxygen requirements, and the use of sedatives and pain
medications (9). Additional research is needed to determine
whether the risk factors identiﬁed also have adverse effects on
cognitive outcomes.
The strengths of this study include the large multicenter
population and the evaluation of post-PICU discharge functioning
and HRQL using reliable and validated instruments, and new
information regarding risk factors for functional decline and
reduced HRQL after a pediatric critical illness (5). The limitations of
this study include the lack of socioeconomic data, estimation of
baseline function based on interviews with the parents and medical
records, lack of baseline HRQL, and parent/proxy report—all of
which the authors acknowledge. Another limitation is the use of the
Pediatric Overall Performance Category and Pediatric Cerebral
Performance Category, which rely on parental/legal guardian
reports rather than on performance-based measures and therefore
may be less sensitive, especially in populations with baseline
impairments (5). Future studies to directly assess functional
outcomes using performance-based measures are needed. Studies
are also needed to characterize outcome trajectories at time points
more distant from the critical illness to understand the trajectories
over time, and to assess the effects of potential interventions.
Determining which factors may be potentially modiﬁable to
improve long-term outcomes after a pediatric critical illness should
also be the focus of future research. n
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